Challenges Faced by Medical Journals During the COVID-19 Pandemic-Reference-Cited by-同舟云学术

Challenges Faced by Medical Journals During the COVID-19 Pandemic

Published:2020-07-01 Issue:19 Volume:38 Page:2206-2207
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Cannistra Stephen A.¹,Haffty Bruce G.²,Ballman Karla³

Affiliation:

1. Division of Hematology and Oncology and Program in Gynecologic Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

2. Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson and New Jersey Medical Schools, New Brunswick, NJ

3. Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.00858

Reference5 articles.

1. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

2. Risk of COVID-19 for patients with cancer

3. Risk of COVID-19 for patients with cancer

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Pandemisi Sürecinde Jinekolojik Kanserli Kadınların Kaygı, Zorluk ve Sağlık Çalışanlarından Beklentileri Üzerine Fenomenolojik Bir Çalışma;Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi;2023-09-26

2. Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review;Clinical Complementary Medicine and Pharmacology;2022-12

3. How German and Italian Laypeople Reason about Distributive Shortages during COVID-19;International Journal of Environmental Research and Public Health;2022-09-23

4. The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence;Journal of Cancer Policy;2022-09

5. Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence;Journal of Cancer Policy;2022-09